Mangiferin: a natural miracle bioactive compound against lifestyle related disorders.

Muhammad Imran, Muhammad Sajid Arshad, Masood Sadiq Butt, Joong-Ho Kwon, Muhammad Umair Arshad, Muhammad Tauseef Sultan
Author Information
  1. Muhammad Imran: Department of Diet and Nutritional Sciences, Imperial College of Business Studies, Lahore, Pakistan.
  2. Muhammad Sajid Arshad: Institute of Home and Food Sciences, Government College University, Faisalabad, 36000, Pakistan. sajid_ft@yahoo.com.
  3. Masood Sadiq Butt: National institute of Food Science and Technology, University of Agriculture Faisalabad, Faisalabad, Pakistan.
  4. Joong-Ho Kwon: School of Food Science and Biotechnology, Kyungpook National University, Daegu, 41566, Republic of South Korea.
  5. Muhammad Umair Arshad: Institute of Home and Food Sciences, Government College University, Faisalabad, 36000, Pakistan.
  6. Muhammad Tauseef Sultan: Department of Food Science and Technology, Bahauddin Zakariya University, Multan, Pakistan.

Abstract

The current review article is an attempt to explain the therapeutic potential of mangiferin, a bioactive compound of the mango, against lifestyle-related disorders. mangiferin (2-β-D-glucopyranosyl-1,3,6,7-tetrahydroxy-9H-xanthen-9-one) can be isolated from higher plants as well as the mango fruit and their byproducts (i.e. peel, seed, and kernel). It possesses several health endorsing properties such as antioxidant, antimicrobial, antidiabetic, antiallergic, anticancer, hypocholesterolemic, and immunomodulatory. It suppresses the activation of peroxisome proliferator activated receptor isoforms by changing the transcription process. mangiferin protects against different human cancers, including lung, colon, breast, and neuronal cancers, through the suppression of tumor necrosis factor α expression, inducible nitric oxide synthase potential, and proliferation and induction of apoptosis. It also protects against neural and breast cancers by suppressing the expression of matrix metalloproteinase (MMP)-9 and MMP-7 and inhibiting enzymatic activity, metastatic potential, and activation of the β-catenin pathway. It has the capacity to block lipid peroxidation, in order to provide a shielding effect against physiological threats. Additionally, mangiferin enhances the capacity of the monocyte-macrophage system and possesses antibacterial activity against gram-positive and gram-negative bacteria. This review summarizes the literature pertaining to mangiferin and its associated health claims.

Keywords

References

  1. Neurochem Res. 2014 Apr;39(4):668-76 [PMID: 24493626]
  2. J Pharm Pharmacol. 2011 Oct;63(10):1336-45 [PMID: 21899550]
  3. Eur J Pharmacol. 2014 Oct 5;740:652-61 [PMID: 24972244]
  4. PLoS One. 2013;8(2):e56894 [PMID: 23451106]
  5. J Cell Biochem. 2012 Aug;113(8):2633-42 [PMID: 22422649]
  6. J Med Food. 2013 Aug;16(8):719-27 [PMID: 23957355]
  7. Z Naturforsch C. 2004 Jul-Aug;59(7-8):481-4 [PMID: 15813365]
  8. J Recept Signal Transduct Res. 2016;36(1):57-66 [PMID: 25798666]
  9. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2004 Oct;12(5):590-4 [PMID: 15498116]
  10. Phytother Res. 2010 Jun;24(6):893-9 [PMID: 19960420]
  11. Int J Mol Med. 2014 May;33(5):1348-54 [PMID: 24626801]
  12. Arch Biochem Biophys. 2008 Sep 15;477(2):253-8 [PMID: 18621015]
  13. Planta Med. 2007 Oct;73(13):1372-6 [PMID: 17918041]
  14. J Pharm Biomed Anal. 2011 Jul 15;55(5):1075-82 [PMID: 21466941]
  15. J Cancer Res Ther. 2014 Oct-Dec;10(4):1033-9 [PMID: 25579550]
  16. Fitoterapia. 2014 Mar;93:54-61 [PMID: 24220727]
  17. Am J Clin Nutr. 2005 Jan;81(1 Suppl):230S-242S [PMID: 15640486]
  18. Food Funct. 2015 Jun;6(6):1847-54 [PMID: 25940566]
  19. Yao Xue Xue Bao. 2010 Oct;45(10):1239-46 [PMID: 21348301]
  20. Chem Biol Interact. 2013 Nov 25;206(2):239-47 [PMID: 24095822]
  21. Zhong Yao Cai. 2007 Mar;30(3):306-9 [PMID: 17634039]
  22. Zhongguo Zhong Yao Za Zhi. 2011 May;36(10):1348-52 [PMID: 21837981]
  23. Toxicol Appl Pharmacol. 2012 Apr 1;260(1):35-47 [PMID: 22310181]
  24. Mini Rev Med Chem. 2013 Mar;13(3):439-55 [PMID: 23190031]
  25. Chem Biol Interact. 2009 May 15;179(2-3):344-50 [PMID: 19026997]
  26. Toxicology. 2002 Jul 15;176(3):165-73 [PMID: 12093613]
  27. Chem Biol Interact. 2011 Sep 5;193(2):129-40 [PMID: 21703249]
  28. Indian J Exp Biol. 2006 Mar;44(3):209-15 [PMID: 16538859]
  29. Biol Pharm Bull. 2005 Apr;28(4):596-600 [PMID: 15802793]
  30. Eur J Pharmacol. 2014 Oct 5;740:337-45 [PMID: 25064341]
  31. J Org Chem. 2004 Aug 6;69(16):5240-6 [PMID: 15287766]
  32. Pharmacol Res. 2000 Dec;42(6):565-73 [PMID: 11058410]
  33. Chemistry. 2000 Mar 17;6(6):1035-41 [PMID: 10785824]
  34. Methods Enzymol. 1990;186:343-55 [PMID: 2172711]
  35. Med Hypotheses. 2014 Nov;83(5):570-4 [PMID: 25204703]
  36. Environ Mol Mutagen. 2005 Jul;46(1):12-21 [PMID: 15795888]
  37. Curr Med Chem. 2015;22(1):150-64 [PMID: 25139462]
  38. PLoS One. 2013 Aug 08;8(8):e71759 [PMID: 23951240]
  39. Int J Mol Sci. 2014 May 20;15(5):9016-35 [PMID: 24853132]
  40. Magn Reson Chem. 2006 Sep;44(9):838-44 [PMID: 16788888]
  41. Mol Nutr Food Res. 2011 Dec;55(12):1809-18 [PMID: 22038976]
  42. Mol Cell Endocrinol. 2015 Apr 15;405:63-73 [PMID: 25681564]
  43. Pharm Biol. 2015 Apr;53(4):503-11 [PMID: 25380307]
  44. Pharmacol Biochem Behav. 2014 Sep;124:311-9 [PMID: 24979217]
  45. Eur J Pharmacol. 2006 Oct 10;547(1-3):31-6 [PMID: 16945365]
  46. Oncol Rep. 2015 Jun;33(6):2815-20 [PMID: 25901555]
  47. J Nutr. 2006 Jan;136(1):52-7 [PMID: 16365058]
  48. Neurobiol Dis. 2006 Aug;23(2):374-86 [PMID: 16806951]
  49. Drug Dev Ind Pharm. 2013 Nov;39(11):1840-50 [PMID: 23167243]
  50. Toxicology. 2005 Nov 5;215(1-2):57-68 [PMID: 16076520]
  51. Eur J Nutr. 2012 Sep;51(6):729-39 [PMID: 21986672]
  52. Mol Vis. 2010 Aug 17;16:1659-68 [PMID: 20806037]
  53. BMB Rep. 2015 Oct;48(10):559-64 [PMID: 25739392]
  54. Nutr Res. 2008 Dec;28(12):879-91 [PMID: 19083501]
  55. Asian Pac J Cancer Prev. 2014;15(17):7065-8 [PMID: 25227792]
  56. Pharmacol Res. 2008 May;57(5):332-8 [PMID: 18450471]
  57. Pharmacol Biochem Behav. 2013 Sep;110:19-26 [PMID: 23747933]
  58. An Acad Bras Cienc. 2014 Dec;86(4):1935-48 [PMID: 25590730]
  59. Experientia. 1991 Feb 15;47(2):195-9 [PMID: 2001725]
  60. Metabolism. 2015 Mar;64(3):428-37 [PMID: 25499441]
  61. Pharmacol Rev. 2003 Mar;55(1):1-20 [PMID: 12615951]
  62. Int J Clin Exp Med. 2015 Nov 15;8(11):19994-20001 [PMID: 26884911]
  63. Can J Physiol Pharmacol. 2013 Sep;91(9):759-63 [PMID: 23984905]
  64. J Sci Food Agric. 2014 May;94(7):1380-8 [PMID: 24114670]
  65. Naunyn Schmiedebergs Arch Pharmacol. 2015 May;388(5):531-8 [PMID: 25653124]
  66. Neurosci Lett. 2007 May 17;418(2):159-64 [PMID: 17433543]
  67. J Trace Elem Med Biol. 2015;31:107-12 [PMID: 26004900]
  68. Hum Exp Toxicol. 2010 May;29(5):409-18 [PMID: 20150354]
  69. Int J Mol Sci. 2014 Sep 11;15(9):16025-42 [PMID: 25216336]
  70. Basic Clin Pharmacol Toxicol. 2008 Aug;103(2):137-42 [PMID: 18816296]
  71. Phytother Res. 2003 Dec;17(10):1203-8 [PMID: 14669257]
  72. Environ Toxicol. 2012 Feb;27(2):117-27 [PMID: 20629087]
  73. Biomed Chromatogr. 2006 Dec;20(12):1304-8 [PMID: 17006966]
  74. Am J Nephrol. 2014;40(5):441-50 [PMID: 25427663]
  75. Acta Pharmacol Sin. 2014 Feb;35(2):257-66 [PMID: 24374812]
  76. Cancer Lett. 2011 Jun 1;305(1):21-31 [PMID: 21420233]
  77. Biol Pharm Bull. 2009 Feb;32(2):242-6 [PMID: 19182383]
  78. J Org Chem. 2010 Aug 20;75(16):5725-8 [PMID: 20704443]
  79. Environ Toxicol Pharmacol. 2008 Nov;26(3):278-82 [PMID: 21791375]
  80. Cell Mol Neurobiol. 2014 Jul;34(5):651-7 [PMID: 24794713]
  81. Toxicology. 2006 Dec 7;228(2-3):135-9 [PMID: 17052832]
  82. PLoS One. 2014 Sep 18;9(9):e107220 [PMID: 25233093]
  83. Pharmacol Rep. 2012;64(4):848-56 [PMID: 23087136]
  84. J Cell Biochem. 2011 Jan;112(1):89-97 [PMID: 20683903]
  85. Yao Xue Xue Bao. 2014 May;49(5):596-601 [PMID: 25151727]
  86. J Recept Signal Transduct Res. 2015 Feb;35(1):76-84 [PMID: 24984103]
  87. Eur J Pharmacol. 2010 Jun 10;635(1-3):124-8 [PMID: 20303935]
  88. Int Immunopharmacol. 2014 Nov;23(1):170-8 [PMID: 25194678]
  89. Drug Res (Stuttg). 2015 Nov;65(11):574-80 [PMID: 25426848]
  90. Chem Pharm Bull (Tokyo). 2000 Aug;48(8):1239-41 [PMID: 10959599]
  91. Arch Pharm Res. 2011 Mar;34(3):469-75 [PMID: 21547680]
  92. Eur J Pharmacol. 2005 Apr 18;513(1-2):47-55 [PMID: 15878708]
  93. Zhong Yao Cai. 2010 Jan;33(1):81-5 [PMID: 20518311]
  94. Biosci Biotechnol Biochem. 2011;75(12):2321-5 [PMID: 22146720]
  95. J Ethnopharmacol. 2005 Mar 21;97(3):497-501 [PMID: 15740886]
  96. Phytomedicine. 2015 Jun 1;22(6):605-14 [PMID: 26055125]
  97. J Nutr Biochem. 2013 Jun;24(6):1173-81 [PMID: 23266284]
  98. Planta Med. 2009 Oct;75(13):1415-7 [PMID: 19533581]
  99. J Pharm Biomed Anal. 2007 May 9;44(1):96-100 [PMID: 17349768]
  100. Diabetes. 2014 Nov;63(11):3626-36 [PMID: 24848064]
  101. Biochim Biophys Acta. 2006 Sep;1760(9):1333-42 [PMID: 16860486]
  102. J Ocul Pharmacol Ther. 2010 Aug;26(4):319-24 [PMID: 20653476]
  103. Life Sci. 2008 May 23;82(21-22):1045-9 [PMID: 18433791]
  104. Free Radic Res. 1999 Dec;31(6):569-73 [PMID: 10630681]
  105. Curr Pharm Des. 2012;18(26):3831-52 [PMID: 22632748]
  106. Asian Pac J Cancer Prev. 2014;15(4):1639-42 [PMID: 24641381]
  107. Genet Mol Res. 2015 May 12;14 (2):4989-5002 [PMID: 25966274]
  108. Arch Biochem Biophys. 2005 Jul 15;439(2):184-93 [PMID: 15979560]
  109. Phytother Res. 2015 Feb;29(2):295-302 [PMID: 25380391]
  110. PLoS One. 2012;7(1):e30782 [PMID: 22292039]
  111. Toxicol Appl Pharmacol. 2013 Oct 1;272(1):180-90 [PMID: 23707762]
  112. PLoS One. 2014 Mar 05;9(3):e90137 [PMID: 24598864]
  113. Org Lett. 2009 Jun 4;11(11):2233-6 [PMID: 19473042]
  114. Psychopharmacology (Berl). 2013 Aug;228(4):585-94 [PMID: 23529380]
  115. Mol Biosyst. 2015 Feb;11(2):418-33 [PMID: 25406416]
  116. Acta Pharmacol Sin. 2014 Dec;35(12 ):1493-503 [PMID: 25418380]

MeSH Term

Anti-Inflammatory Agents
Antineoplastic Agents, Phytogenic
Antioxidants
Cardiovascular Diseases
Cognitive Dysfunction
Diabetes Mellitus, Type 2
Humans
Hyperlipidemias
Hypoglycemic Agents
Mangifera
Neoplasms
Neuralgia
Nootropic Agents
Oxidative Stress
Xanthones

Chemicals

Anti-Inflammatory Agents
Antineoplastic Agents, Phytogenic
Antioxidants
Hypoglycemic Agents
Nootropic Agents
Xanthones
mangiferin

Word Cloud

Created with Highcharts 10.0.0cancerspotentialmangiferinMangiferinreviewbioactivecompoundmangodisorderspossesseshealthactivationprotectsbreastexpressionactivitycapacityclaimscurrentarticleattemptexplaintherapeuticlifestyle-related2-β-D-glucopyranosyl-1367-tetrahydroxy-9H-xanthen-9-onecanisolatedhigherplantswellfruitbyproductsiepeelseedkernelseveralendorsingpropertiesantioxidantantimicrobialantidiabeticantiallergicanticancerhypocholesterolemicimmunomodulatorysuppressesperoxisomeproliferatoractivatedreceptorisoformschangingtranscriptionprocessdifferenthumanincludinglungcolonneuronalsuppressiontumornecrosisfactorαinduciblenitricoxidesynthaseproliferationinductionapoptosisalsoneuralsuppressingmatrixmetalloproteinaseMMP-9MMP-7inhibitingenzymaticmetastaticβ-cateninpathwayblocklipidperoxidationorderprovideshieldingeffectphysiologicalthreatsAdditionallyenhancesmonocyte-macrophagesystemantibacterialgram-positivegram-negativebacteriasummarizesliteraturepertainingassociatedMangiferin:naturalmiraclelifestylerelatedBioactivemoleculesHealthHumanNutritionToxicity

Similar Articles

Cited By